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Background: Diabetes prevalence increases with age. In 2019, the IDF estimated the number of
diabetic people above 65 years is 135.6 million (19.3%), expected to be 276.2 million in 2045,
leading to a significant increase in the diabetes population of the aging societies in the next 25

Keywords

years and the inevitable public health, and economic challenges this will bring. Aim: To evaluate
how clinical characteristics, degree of control of glycemia, and presence of chronic complications
differ between older and younger T2DM subjects. Methods: A cross-sectional study that includes



T2DM

200 T2DM participants were classified into 2 groups. Group A includes 100 young subjects



older diabetics

(<65years). Group B includes 100 old subjects (>65years). Detailed clinical history was taken.



younger

Also, HbA1c was measured. Results: Glycemic control was achieved in 46% of older diabetics

diabetics

vs. 37% of younger diabetics (HbA1c 7.2 vs 7.8), but statistically insignificant. Univariate



HbA1c

analysis revealed non-obese vs. obese, DBP ≤85 vs >85, TC level ≤158 mg/dl vs >158, and TG



International

level ≤129 mg/dl vs. >129 were statistically significant predictors of diabetic control. Multivariate

Diabetes
Federation
(IDF).

analysis revealed non-obese state (OR=2.2) and DBP≤85mmHg (OR=2.1) were statistically
significant independent predictors of the likelihood of diabetic control. The best cut-off values for
DBP, TC, TG were 85, 158, 129, and the AUC were 0.593 (p=0.016), 0.579 (p=0.053), 0.574
(p=0.072) respectively, to identify the optimal levels for the prediction of a controlled diabetic
state. Conclusion: Control of glycemia and cardiovascular risk factors was better in the elderly
T2DM subjects, however, the complications were more common among them.
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INTRODUCTION

higher risk for cardiovascular diseases and a higher

Diabetes is a huge and rapidly growing

rate of morbidity and mortality than older people

health problem worldwide. In 2019, IDF estimated

without diabetes. Also, they are at higher risk for

that the number of people with diabetes was 463

functional

million and expected to be 578 million by 2030,

common geriatric syndromes

and 700 million by 2045. Two-thirds of people

cognitive impairment, urinary incontinence, falls,

with diabetes live in urban areas, and one in five

and persistent pain [5].

people with diabetes is above 65 years [1].

disabilities,

polypharmacy,
as

and

depression,

Some older people don't have any

T2DM is characterized by peripheral

complications and are easy to manage while

insulin resistance and pancreatic β-cell failure,

others, are multi complicated and have additional

leading to major comorbidity and mortality as a

severe diseases difficult to treat even in highly

result of micro and macrovascular complications

specialized centers [6]. The main troublesome

[2]. Globally, T2DM represents 90%-95% of

comorbidities in the elderly are heart and kidney

overall diabetic cases and still increasing [3].

insufficiencies leading to a limitation in medicine

The prevalence of diabetes increases with

prescription [7].

age so, the highest estimated prevalence is in

Blood glucose targets vary according to

people older than 65. In 2019, IDF estimated that

the patient’s health status and life expectancy.

the number of people with diabetes above 65 years

According to IDF recommendations, older people

is 135.6 million (19.3%). If this trend continues,

who are physically fit or independent and

the number will be 195.2 million in 2030 and

cognitively intact should have a hemoglobin A1c

276.2 million in 2045, leading to a significant

(HbA1c) below 7%, which means a rate similar to

increase in the diabetes population of the aging

one of younger diabetics because of their long life

societies in the next 25 years and the inevitable

expectancy [8].

public health and economic challenges this will
bring [1].

In the view of these data, we aimed to
evaluate how clinical characteristics, degree of

The strong link between age and diabetes

control of glycemia, and presence of chronic

is of great concern due to a progressive increase in

complications differ between older and younger

life expectancy, which is likely to result in a

subjects with T2DM.

substantial increase in the number of older people

Methods:

with diabetes, and a concomitant increase in the

Patients:

costs for the health system shortly. There is

This

observational,

Cross-Sectional,

compelling evidence that diabetes in older people

comparative study includes 200 participants, 100

has differential characteristics compared with

old subjects (>65years) with T2DM, and 100

diabetes in middle-aged or earlier people [4].

young subjects (<65years) with T2DM. In all

Older diabetics have a similar risk for micro

cases, both men and women were recruited from

and macrovascular complications as younger

subjects attending diabetes and endocrinology

diabetics. However, they have a more absolute

outpatient clinic at Mansoura specialized medical
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hospital, Mansoura University, Egypt. The study

kilograms divided by the square of their height in

was carried out over the period from June 2019 to

meters, like weight/height2 [kg/m2]. According to

June 2020. The agreement to participate in the

the NIH 1998 Clinical Guidelines, overweight was

study by informed written consent was approved

defined as a BMI of 25 to 29.9 kg/m2 and obesity

by the local ethical committee at the Mansoura

greater than 30 kg/m2 [9].

faculty of medicine. This research was approved

All participants were evaluated regarding

by Institutional Review Board (IRB) Mansoura

various microvascular complications such as

Faculty of Medicine, Mansoura University. The

diabetic retinopathy using fundus camera & retinal

diabetic

excluded

imaging (TRC-50DX Series). The quantitative

according to the revised American Diabetes

urine albumin/creatinine ratio in the morning spot

Association criteria.

urine samples, eGFR, increased BUN, and

The following were excluded:

creatinine was used for the standard diagnosis of

state

was

confirmed

or

1) Subjects with Type 1 Diabetes mellitus.

diabetic nephropathy. Diabetic neuropathy was

2) Subjects with Gestational Diabetes.

diagnosed based on clinical data available and

3) Subjects who are seriously ill.

EMG. Also, ECG was performed.

4) Subjects with other endocrinal disorders

Blood

and pregnant women.

Sampling

and

Biochemical

Measurements:

5) Subjects refuse to participate in the study.

After overnight fasting (12h), venous

Grouping of the patients:

blood samples (5 ml) were withdrawn from each

The 200 participants classified into 2 groups:

subject via proper venipuncture technique under





Group A: 100 young subjects

complete aseptic condition. A complete hemogram

(<65years) with T2DM (29 men, 71

was performed by using an automatic blood

women).

counter

(CBC

Analyzer

Sysmex

XP300,

subjects

Germany). HbA1c was measured by the ion-

(>65years) with T2DM (45 men and

exchange chromatography method (Biosystem co,

55 women).

Spain). Plasma glucose was measured by the

Group

B:

100

old

Clinical and Anthropometric Measurements:

glucose oxidase method (Cobas Integra 400 plus,

All participants were subjected to full

Germany). Total cholesterol (TC), triglyceride

medical history, anthropometric measurements as

(TG), and high-density lipoprotein cholesterol

weight, height, and body mass index (BMI)), and

(HDL-C),

complete

clinical

spectrophotometric method (Human, Germany).

reference

to

any

examination
micro

or

with

specific

macrovascular

complications.
Weight and height were measured using
calibrated instruments after removal of heavy

Low-density

levels

were

lipoprotein

measured

cholesterol

by

(LDL-C)

levels were calculated using the Friedewald
equation LDL = TC – HDL – (TG/5), provided
that TG level not above 400 mg/dl [10].

clothes and asking participants to take off their
shoes. BMI was computed as a person’s weight in

Published by Mansoura Medical Journal, 2023
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present the results whenever needed including Bar

Statistical analysis:
Data were entered and analyzed using

chart and ROC curves.

IBM-SPSS software (IBM Corp. Released 2017.

Results:

IBM SPSS Statistics for Windows, Version 25.0.

Demographic data of subjects:

Armonk, NY: IBM Corp.) Qualitative data were

Our

200

diabetic

participants

were

expressed as frequency (N) and percentage (%).

classified into two groups: Younger diabetic (<65

Quantitative

for

years) group included 100 (29 men, 71 women)

normality using Shapiro-Wilk’s test with data

subjects with age ranges from 32 to 64 years and

being normally distributed if, p>0.050. The

the Older diabetic (≥65 years) group included 100

presence of significant outliers (extreme values)

(45 men and 55 women) subjects with age ranges

was tested by inspecting the boxplots. Quantitative

from 65 to 84 years.

data were expressed as mean ± standard deviation

Qualitative and Quantitative characteristics

(SD) if normally distributed, or median and

between the two groups

data

were

initially

tested

interquartile range (IQR) if not. IQR = 75th

Table (1) showed that glycemic control

percentile minus 25th percentile. Qualitative data

was achieved in 46% of older diabetics vs. 37% of

were

younger diabetics, but this difference wasn’t

compared

by

the

Chi-Square

test.

Quantitative data in two groups were compared by

statistically

Independent-Samples

normally

hypertension was more in older diabetics. For

distributed data in both groups) or its non-

antihypertensive medications, monotherapy was

parametric equivalent; Mann-Whitney U test if

more in younger diabetics while dual therapy was

data were not normally distributed in one or both

more in older diabetics. Only 4% of older diabetics

groups and/or significant outliers. The Receiver

were on triple therapy. The use of antiplatelet

Operating Characteristic (ROC) curves were used

therapy was more in older diabetics. It also showed

to define the cut-points that discriminate between

that ideal weight and overweight were more in

diabetic control vs. diabetic uncontrolled state for

older diabetics while obesity grades II and III were

DBP, TC, and TG. Binary logistic regression was

more in younger diabetics. It also showed that IHD

run to ascertain the effects of predictor variables

and diabetic retinopathy were both more in older

on the likelihood that participants will exhibit

diabetics.

t-Test

(for

significant.

It

showed

that

diabetic control. Initially, univariate analysis was

Also, this table showed a lower median

run to get crude odds ratios (COR) with their 95%

hemoglobin A1c in older diabetics vs. younger

confidence

by

diabetics (7.2 vs 7.8), but this difference wasn’t

multivariate analysis to get the independent

statistically significant. This table showed a

predictors with their odds ratios (OR) and 95% CI.

statistically

For any of the used tests, results were considered

diabetes and HDL-C in older diabetics vs. younger

interval

(95%

statistically significant

if

CI)

followed

p-value

≤

0.050.

significantly

higher

duration

of

diabetics.

Appropriate charts were used to graphically

https://mmj.mans.edu.eg/home/vol50/iss3/1
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Table (1): Qualitative and Quantitative characteristics between the two groups
Characteristic
Younger diabetic
Older diabetic
P value
2
(N=100)
(N=100)
> 7%
63
54
1.668
0.196
Glycemic
control
≤ 7%
37
46
Oral
44
45
4.090
0.129
Antidiabetic
Insulin
39
28
drugs
Both
17
27
Positive
76
91
8.165
0.004
FET
Hypertension Monotherapy
0.004
46 (60.5%) a
35 (38.5%) b
Dual therapy
30 (39.5%) a
52 (57.1%) b
Triple therapy
0 (0%) a
4 (4.4%) a
57
77
9.046
Antiplatelet use
0.003
43
42
0.020
0.886
Statin use
Ideal
3
7
11.672
0.020
Overweight
12
26
BMI
Obese Class I
30
32
category
Obese Class II
34
24
Obese Class III
21
11
Current smoker
6
12
3.537
0.171
Smoking
status
Non-smoker
79
68
Ex-smoker
15
20
12
25
5.604
Ischemic Heart Disease
0.018
83
89
1.495
0.221
Diabetic Neuropathy
40
56
5.128
Diabetic Retinopathy
0.024
Median (MinMedian (MinQuantitative
Z
P value
Max)
Max)
7.8 (6.5-10.5)
7.2 (6.6-9.3)
-1.063
0.288
Hemoglobin A1c%
7 (4-11)
11 (5-17.8)
-3.599
DM duration (years)
<0.001
120 (120-130)
130 (120-130)
-0.282
0.778
SBP (mmHg)
80 (80-90)
80 (80-90)
-1.492
0.136
DBP (mmHg)
96.7
(93.3-103.3)
96.7
(90-103.3)
-0.865
0.387
MAP (mmHg)
173.5 (140-210)
183 (151.5-210.8)
-1.239
0.215
Total cholesterol (mg/dL)
40 (36.3-47.5)
44 (39-50)
-2.555
HDL-C (mg/dL)
0.011
107 (70.5-135.5)
113 (81-138)
-0.646
0.518
LDL-C (mg/dL)
116 (89-159.8)
121.5 (89.3-161.8)
-0.181
0.857
Triglycerides (mg/dL)
0.8 (0.7-1.0)
0.8 (0.6-0.9)
-1.486
0.137
Serum creatinine (mg/dL)
2
83 (68-112)
102 (70.8-129.8)
-1.549
0.121
eGFR (ml/min/1.73 m )
33 (24.3-53)
37 (23-82)
-0.298
0.765
Albumin creatinine ratio (mg/g)
Data are expressed as N and compared by Chi-Square test. For antihypertensive use, data expressed as N (%)
and compared by Fisher’s exact test (FET). Also, data are expressed as Median (IQR) and compared by MannWhitney U-test.
Qualitative and Quantitative characteristics

Table

between the two glycemic control groups

statistically

There was no statistically significant

(2)

except

for

significantly

obesity

which

more

frequent

was
in

uncontrolled vs. controlled group (p=0.001).

difference in all qualitative parameters between

Also, Table (2) showed a statistically

controlled and uncontrolled groups as shown in

significantly higher DBP, MAP, and BMI in the

Published by Mansoura Medical Journal, 2023
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uncontrolled vs. controlled group (p=0.017, 0.044,

these differences didn’t achieve a statistical

0.005), respectively. It also showed lower values

significance. There was no statistically significant

for age, and higher values for serum TC and TG in

difference as regards DM duration, SBP, HDL-C,

the uncontrolled vs. controlled group. However,

LDL-C, serum creatinine, eGFR, and ACR.

Table (2): Qualitative and Quantitative characteristics between the two glycemic control groups
Characteristic

A1c > 7%
(N=117)
54 (46.2%)
63 (53.8%)
49 (41.9%)
40 (34.2%)
28 (23.9%)
100 (85.5%)
48 (48.0%)
50 (50.0%)
2 (2.0%)
81 (69.2%)
50 (42.7%)
6 (5.1%) a
12 (10.3%) a
39 (33.3%) a
40 (34.2%) a
20 (17.1%) a
18 (15.4%)
99 (84.6%)
9 (7.7%)
93 (79.5%)
15 (12.8%)
19 (16.2%)
104 (88.9%)
58 (49.6%)
Median (Min-Max)
62 (51-67.5)
9 (4-13.5)
130 (120-130)
80 (80-90)
96.7 (93.3-103.3)
35 (31-38.5)
184 (154-214)
41 (37-50)
112 (71.3-142.5)
123 (92.5-169)
0.8 (0.6-1.0)
94 (67.5-121)
32 (24-63)

≥ 65%
< 65%
Oral
Insulin
Both
Positive
Monotherapy
Dual therapy
Triple therapy

Age groups
Antidiabetic
drugs
Hypertension

Antiplatelet use
Statin use
Ideal
Overweight
Obese Class I
BMI category
Obese Class II
Obese Class III
Non-obese
Obesity
Obese
Current smoker
Smoking status
Non-smoker
Ex-smoker
Ischemic Heart Disease
Diabetic Neuropathy
Diabetic Retinopathy
Quantitative
Age (years)
DM duration (years)
SBP (mmHg)
DBP (mmHg)
MAP (mmHg)
BMI (kg/m2)
Total cholesterol (mg/dL)
HDL-C (mg/dL)
LDL-C (mg/dL)
Triglycerides (mg/dL)
Serum creatinine (mg/dL)
eGFR (ml/min/1.73 m2)
Albumin creatinine ratio (mg/g)

A1c ≤ 7%
(N=83)
46 (55.4%)
37 (44.6%)
40 (48.2%)
27 (32.5%)
16 (19.3%)
67 (80.7%)
33 (49.3%)
32 (47.8%)
2 (3%)
53 (63.9%)
35 (42.2%)
3 (3.6%) a
26 (31.3%) b
24 (28.9%) a
18 (21.7%) a
12 (14.5%) a
29 (34.9%)
54 (65.1%)
9 (10.8%)
54 (65.1%)
20 (24.1%)
18 (21.7%)
68 (81.9%)
38 (45.8%)
Median (Min-Max)
66 (56-68)
8 (5-14)
130 (120-130)
80 (70-90)
93.3 (90-103.3)
32 (29-37)
176 (136-203)
41 (38-49)
103.5 (72-134)
112 (84-148)
0.8 (0.6-0.9)
88 (70-118)
37 (24-66)

2

P value

1.668

0.196

0.953

0.621

0.794
FET

0.373
0.912

0.635
0.006
FET

0.426
0.936
0.005

10.328

0.001

5.438

0.066

0.956
1.954
0.279
Z
-1.793
-0.232
-1.214
-2.378
-2.011
-2.803
-1.892
-0.238
-0.971
-1.785
-0.859
-0.859
-0.608

0.328
0.162
0.597
P value
0.073
0.816
0.225
0.017
0.044
0.005
0.058
0.812
0.332
0.074
0.390
0.848
0.543

Data are expressed as N and compared by Chi-Square test. For antihypertensive use, data expressed as N (%) and compared by
Fisher’s exact test (FET). Also, data are expressed as Median (IQR) and compared by Mann-Whitney U-test.
Qualitative and Quantitative characteristics in

quantitative parameters between controlled and

elderly diabetics

uncontrolled elderly diabetics groups except for

Table

(3),

showing

no

statistically

smoking status, obesity which was statistically

significant difference in all qualitative and

significantly more frequent in uncontrolled vs.

https://mmj.mans.edu.eg/home/vol50/iss3/1
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controlled group and sex where female patients are

uncontrolled vs. controlled elderly diabetics

more frequent in the uncontrolled group. Also,

groups.

BMI was statistically significantly higher among
Table (3): Qualitative and Quantitative characteristics in elderly diabetics
Characteristic
A1c > 7%
A1c ≤ 7%
P value
2
(N=54)
(N=46)
Male
19 (35.2%)
26 (56.5%)
4.569
Sex
0.033
Female
35 (64.8%)
20 (43.5%)
Oral
22 (40.7%)
23 (50%)
1.349
0.510
Antidiabetic drugs
Insulin
15 (27.8%)
13 (28.3%)
Both
17 (31.5%)
10 (21.7%)
Positive
49 (90.7%)
42 (42.9%)
FET
1.000
Hypertension
FET
0.717
Monotherapy
17 (34.7%)
18 (49.3%)
Dual therapy
30 (61.2%)
22 (52.4%)
Triple therapy
2 (4.1%)
2 (4.8%)
45 (83.3%)
32 (69.6%)
2.659
0.103
Antiplatelet use
23 (42.6%)
19 (41.3%)
0.017
0.896
Statin use
Ideal
4 (7.4%) a
2 (4.3%) a
FET
0.001
Overweight
5 (9.3%) a
21 (45.7%) b
Obese Class I
24 (44.4%) a
9 (19.6%) a
BMI category
Obese Class II
15 (27.8%) a
9 (19.6%) a
Obese Class III
6 (11.1%) a
5 (10.9%) a
Non-obese
9 (16.7%)
23 (50%)
12.684
Obesity
<0.001
Obese
45 (83.3%)
23 (50%)
Current smoker
5 (9.3%)
7 (15.2%)
7.707
Smoking status
0.021
Non-smoker
43 (79.6%)
25 (54.3%)
Ex-smoker
6 (11.1%)
14 (30.4%)
11 (20.4%)
14 (30.4%)
1.342
0.247
Ischemic Heart Disease
49 (90.7%)
40 (87%)
0.363
0.547
Diabetic Neuropathy
32 (59.3%)
24 (52.2%)
0.506
0.477
Diabetic Retinopathy
Quantitative
Median (Min-Max)
Median (Min-Max)
Z
P value
68 (66-70.3)
67.5 (76-72)
-0.759
0.448
Age (years)
11.5 (5-18)
10 (5-17.5)
-0.010
0.992
DM duration (years)
130 (120-130)
130 (120-130)
-0.025
0.980
SBP (mmHg)
80 (80-90)
80 (70-90)
-1.637
DBP (mmHg)
0.102
96.7 (93.3-103.3)
93.3 (90-103.3)
-0.981
0.326
MAP (mmHg)
33 (30.8-37.3)
29 (27-36)
-2.382
BMI (kg/m2)
0.017
191.5 (158.3-219.5)
178 (141.2-205)
-1.639
0.101
Total cholesterol (mg/dL)
44 (39.8-50)
42.5 (38.7-50)
-0.499
0.618
HDL-C (mg/dL)
113 (84-143.5)
112.5 (77.8-132.2)
-0.923
0.356
LDL-C (mg/dL)
130 (91.3.5-170.8)
110.5 (87-151)
-1.203
0.229
Triglycerides (mg/dL)
0.75 (0.6-1.0)
0.8 (0.6-0.9)
-0.098
0.922
Serum creatinine (mg/dL)
101 (64.3-127.5)
102 (76-139.5)
-0.827
0.408
eGFR (ml/min/1.73 m2)
37 (23-84.2)
35 (22-82)
-0.478
0.633
Albumin creatinine ratio (mg/g)
Data are expressed as N and compared by Chi-Square test. For antihypertensive use, data expressed as N (%) and
compared by Fisher’s exact test (FET). Also, data are expressed as Median (IQR) and compared by Mann-Whitney U-test.

Predictors of the likelihood of controlled

mmHg, TC level ≤158 mg/dl, and TG level ≤129

diabetic state

mg/dl on the likelihood that participants will

Table (4), showing the results of binary

achieve diabetic control. Univariate analysis

logistic regression, which was run to ascertain the

revealed that non-obese vs. obese, DBP ≤85 vs

effects of age ≥65 years, non-obese state, DBP≤85

>85, TC level ≤158 mg/dl vs >158, and TG level

Published by Mansoura Medical Journal, 2023
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≤129 mg/dl vs. >129 were statistically significant

times higher odds than obese diabetics to exhibit

predictors of diabetic control. Age wasn't a

diabetic control and diabetics with DBP ≤85

statistically significant predictor. Multivariate

mmHg have 2.1 times higher odds than diabetics

analysis was run and revealed that only non-obese

with DBP>85 mmHg to exhibit diabetic control.

state and DBP ≤85 mmHg were statistically

This model was statistically significant (2[5] =

significant independent predictors of the likelihood

22.22, P<0.001) and correctly classified 66% of

of diabetic control. Non-obese diabetics have 2.2

cases.

Table (4): Predictors of the likelihood of controlled diabetic state
Predictor

Univariate analysis

<65 years

Age

P value

COR

95% CI

P value

COR

95% CI

0.197

R

R

0.493

R

R

1.45

0.82-2.55

1.24

0.67-2.29

R

R

R

R

2.95

1.5-5.8

2.2

1.1-4.5

R

R

R

R

2.36

1.27-4.36

2.1

1.1-4.1

R

R

R

R

1.94

1.1-3.5

1.6

0.8-3.1

R

R

R

R

2.13

1.1-3.6

1.7

0.9-3.2

≥65 years
Obesity status

Obese

0.002

Non-obese
DBP (mmHg)

>85

0.006

≤85
TC (mg/dl)

>158

0.030

≤158
TG (mg/dl)

>129

Multivariate analysis

0.020

≤129

0.030

0.020

0.148

0.102

some

were 85.0, with the area under the curve (AUC)

parameters for prediction of controlled diabetic

was 0.593 (p=0.016). TC best cut-off values were

state

158, with the area under the curve (AUC) was

Performance

characteristics

of

In Table (5), ROC analysis was conducted

0.579 (p=0.053). TG best cut-off values were 129,

to identify the optimal levels for the prediction of a

with the area under the curve (AUC) was 0.574

controlled diabetic state. DBP best cut-off values

(p=0.072).

Table (5): Performance characteristics of some parameters for prediction of controlled diabetic state.
AUC

p

Cut

Sensitivity

Specificity

off

(%)

(%)

DBP (mmHg)

0.593

0.016

85.0

74.7

44.4

TC (mg/dl)

0.579

0.053

158

42.2

72.6

TG (mg/dl)

0.574

0.072

129

68.7

47.9
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older diabetics vs. younger diabetics (7.2 vs 7.8),

Discussion:
Diabetes is a chronic disease that harms
different organs due to the negative effect of
hyperglycemia and requires ongoing management.
There is evidence that diabetic complications,
mortality, and hospitalization are more prevalent
among older people with diabetes [11].
The

relationship

between

but this difference wasn’t statistically significant.
However, the duration of diabetes was statistically
significantly higher in older diabetics vs. younger
diabetics.
These results came in agreement with AlMukhtar et al. who showed that younger diabetic

age

and

glycemic control has been reported to be
questionable. Some studies have reported a high
prevalence of poor control in the elderly, some
studies point to no effect of age on metabolic
control, to better glycemic control among older
people, and even point to an inverse relationship
between age and glycemic control [12].
On the other hand, worse glycemic control
and lipid profile, higher prevalence of obesity and
additional cardiovascular risk factors, remarkable
increase in the risk of cardiovascular disease,
higher rate of death from the hyperglycemic crisis,
were reported among younger type 2 diabetic
subjects by some studies [13].
Older people with T2DM are a growing
population that accounts for approximately 50% of
all cases of diabetes in adults and have differential
characteristics, requiring tailored management
approaches [5].

subjects have a significantly elevated level of
HbA1c compared with older diabetic subjects [14].
Similar results were obtained by Shamshigaran et
al. who noted that poor glycemic control was
detected in 70.4% of the younger age group and
63.0% of the older age group with no statistical
significance [12].
In the same context, Barrot-de la Puente
et al. reported that the percentage of subjects with
fair glycemic control (HbA1c ≤ 7%) was
significantly higher among older age groups in
both genders (p < 0.001) despite longer diabetes
duration in older age groups [13]. Similarly, some
studies reported better glycemic control among the
older age groups [15,16].
In our current study, hypertension was
more in older diabetics. For antihypertensive
medications, monotherapy was more in younger
diabetics while dual therapy was more in older
diabetics. Only 4% of older diabetics were on
triple therapy. The use of antiplatelet therapy was

The main objective of this Cross-Sectional
study was to evaluate how clinical characteristics,
degree of control of glycemia, and presence of
chronic complications differ between older and
younger subjects with T2DM.

more in older diabetics. It also showed that IHD
and diabetic retinopathy were both more in older
diabetics.

HDL-C

level

was

statistically

significantly higher in older diabetics vs. younger
diabetics.

In our current study, the glycemic control
was achieved in 46% of older diabetics vs. 37% of
younger diabetics, with lower median HbA1c in
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Such results agreed with Shamshigaran et
al. who reported that hypertension was more
significantly

frequent

among

older

difference regarding BMI among both younger and
older diabetic subjects [12].

diabetic

patients compared to younger diabetic patients.
Moreover, complications were higher among the
elderly compared to younger participants (57.1%
vs. 45.2%. P = 0.003). The frequencies of
complications in their study according to the
patient’s clinic record were neuropathy (34.9%),
retinopathy (16%), nephropathy (5.9%), stroke

As

regards

qualitative

characteristics

between the two glycemic control groups, our
current

study revealed

that

no

statistically

significant difference in all qualitative parameters
between controlled and uncontrolled groups except
for obesity which was statistically significantly
more frequent in the uncontrolled vs. controlled
group.

(1.6%), and cardiovascular disease (6.1%) [12].
Such results agreed with Haghighatpanah
In contrary to these results, Al-Mukhtar
et al. stated that the younger diabetic subjects were
found to have a significantly longer duration of
disease and a significant increase in SBP and DBP
in comparison with the older subjects (p<0.005).
Also, there was a significant elevation of TC, TG,
and LDL-C in younger diabetic compared to older
diabetic [14].
In our current study, ideal weight and
overweight were more in older diabetics while
obesity class II and III were more in younger
diabetics.

et al. who stated that subjects with poor glycemic
control (HbA1c>7%) were more obese than
subjects with good glycemic control (HbA1c<7%)
[18]. Also, Anioke et al. reported that waist-hip
ratio (WHR) was significantly higher among
subjects with poor glycemic control (HbA1c>7%)
than

subjects

with

good

glycemic

control

(HbA1c<7%) [19].
Regarding

quantitative

characteristics

between the two glycemic control groups, our
current study revealed a statistically significantly
higher DBP, MAP, and BMI in uncontrolled vs.

This was in agreement with Al-Mukhtar

controlled groups. It also showed lower values for

et al. who reported that the BMI of the younger

age and higher values for serum TC and TG in the

diabetic subjects was significantly higher than in

uncontrolled vs. controlled group. However, these

older subjects. Significant increase of overweight

differences didn’t achieve a statistical significance.

and obese frequency in younger diabetic subjects

There was no statistically significant difference as

compared to older diabetic subjects [14]. Also,

regards DM duration, SBP, HDL-C, LDL-C,

Sattar et al. stated that there was a significant

serum creatinine, eGFR, and ACR.

reduction of BMI in older age groups compared to
younger age groups [17].

A study done by Anioke et al. showed no
significant difference regarding TC and HDL-C

In contrast to these results, Shamshigaran

levels among both groups with good or poor

et al. documented that there was no significant

glycemic control. However, the poor glycemic
control group (HbA1c>7%) had significantly
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higher systolic blood pressure and LDL-C levels

The results of multivariate analysis in the

compared with the good glycemic control group

Haghighatpanah et al. study showed that females

(HbA1c<7%) [19].

(OR=2.07), subjects < 65 years old (OR=1.67),

Another study done by Alzahrani et al.
noted that no significant difference regarding TC,
HDL-C, LDL-C levels, and age among subjects

abnormal HDL-C level (OR=1.72), duration of
diabetes >10 years, and types of diabetes
medications, were all significantly associated with
poor glycemic control [18].

with and without glycemic control [20].

Khanthaboon et al. stated that diabetic

Regarding Predictors of the likelihood of
controlled diabetic state, in our current study
multivariate analysis was run and revealed that
only non-obese state and DBP≤85 mmHg were
statistically significant independent predictors of
the likelihood of diabetic control. Non-obese
diabetics have 2.2 times higher odds than obese
diabetics to exhibit diabetic control and diabetics

subjects with secondary school completed or more
were 2.85 times more likely to control HbA1C
than those with an education level ≤ primary
school (OR=2.85; 95% CI=1.17-6.98). Subjects
with insulin therapy controlled their HbA1C level
better than other groups (OR=3.04; 95%Cl=1.10–
8.35; p=0.031) [23].

with DBP≤85 mmHg have 2.1 times higher odds

Regarding performance characteristics of

than diabetics with DBP>85 mmHg to exhibit

some parameters for prediction of controlled

diabetic control.

diabetic state, the present study revealed DBP best

Sazlina et al. in their study reported that
patient

characteristics

glycemic

control

were

associated
younger

with

poor

age

group

(OR=1.96), T2DM duration > 10 years (OR=1.75),
elevated BP (OR=1.10), LDL-C (OR=1.48), and
TG (OR=1.61) [21].

cut-off values were 85.0, with the area under the
curve (AUC) was 0.593 (p=0.016). TC best cut-off
values were 158, with the area under the curve
(AUC) was 0.579 (p=0.053). TG best cut-off
values were 129, with the area under the curve
(AUC) was 0.574 (p=0.072).
To our knowledge, no other study assesses

Mobula et al. demonstrated that male
gender (OR=0.66, increasing age (OR=0.97) and
dual diagnosis of diabetes and hypertension
(OR=0.69) had positive associations with good

the ROC curve of any of the previous parameters
for the prediction of a controlled diabetic state.
Conclusion:

glycemic control. While, duration of diabetes
diagnosis (OR = 1.04), the absence of the Ghana
National Health Insurance Scheme (OR=1.41), and
the number of diabetes medicines (OR=1.73) were
adversely associated with poor glycemic control
[22].

Glycemic control was achieved in 46% of
older diabetics vs. 37% of younger diabetics (mean
HbA1c 7.2 vs 7.8), but this difference wasn’t
statistically
showed

that

Multivariate

non-obese

state

analysis
(OR=2.2;

95%CI=1.1-4.5; p=0.030) and DBP≤85mmHg
(OR=2.1;
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